VERALOX Therapeutics
Latest round
- Series A
Last raised
- Jun 2023
Total raised
- $46M
Investors
- 14
About VERALOX Therapeutics
VERALOX Therapeutics Inc. was founded in 2018 in Frederick, US, specializing in therapies for immune-mediated diseases. The founders, David Maloney, Jeffrey Strovel, and Matthew Boxer, have backgrounds in healthcare innovation.Veralox Therapeutics develops therapies targeting immune-mediated diseases, with a lead product, VLX-1005, designed to inhibit 12-lipoxygenase (12-LOX). This product has received Orphan Designation and Fast Track Designation, indicating its potential significance. Veralox has also secured an exclusive agreement to acquire Nudge Therapeutics to enhance its product portfolio with novel cGAS inhibitors aimed at preventing Type 1 interferon overproduction.000 mn.000 mn to advance the Phase 2 clinical trial for VLX-1005, targeting Heparin-Induced Thrombocytopenia (HIT). The company is focusing on expanding its market presence in North America and Europe, with the aim of launching new products and enhancing its therapeutic offerings. The acquisition of Nudge Therapeutics is expected to bolster its portfolio with innovative solutions for Type 1 Diabetes, further addressing unmet medical needs.
Who invested in VERALOX Therapeutics
14 investors across 3 rounds
See all investors in VERALOX Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about VERALOX Therapeutics
Who invested in VERALOX Therapeutics?
VERALOX Therapeutics has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has VERALOX Therapeutics raised?
VERALOX Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did VERALOX Therapeutics last raise money?
VERALOX Therapeutics's most recent round on record is a Series A, in Jun 2023.
What does VERALOX Therapeutics do?
VERALOX Therapeutics is a biotechnology company.
Where is VERALOX Therapeutics headquartered?
VERALOX Therapeutics is headquartered in Frederick, US.
Which VCs invest in companies like VERALOX Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at VERALOX Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like VERALOX Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.